Atara Biotherapeutics Inc
SWB:AT2
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Atara Biotherapeutics Inc
SWB:AT2
|
US |
|
Q
|
Qube Holdings Ltd
F:1K1
|
AU |
|
P
|
Panasonic Holdings Corp
SWB:MATA
|
JP |
|
C
|
China All Access (Holdings) Ltd
XBER:C5K
|
HK |
|
C
|
Compagnie de Saint Gobain SA
XBER:GOB
|
FR |
|
T
|
Tyson Foods Inc
DUS:TF7A
|
US |
|
U
|
Union Pacific Corp
DUS:UNP
|
US |
|
S
|
Silvercorp Metals Inc
SWB:S9Y
|
CA |
|
T
|
Teva Pharmaceutical Industries Ltd
SWB:TEV
|
IL |
|
Vector Ltd
NZX:VCT
|
NZ |
|
P
|
Procter & Gamble Co
XHAM:PRG
|
US |
|
ARE Holdings Inc
F:A19
|
JP |
|
Money Forward Inc
F:47D
|
JP |
|
C
|
Ceconomy AG
DUS:CEC
|
DE |
|
S
|
Sharc International Systems Inc
F:IWIA
|
CA |
|
F
|
Finnair Oyj
SWB:FAI
|
FI |
|
A
|
Air Canada
SWB:ADH2
|
CA |
|
C
|
Chorus Ltd
XMUN:7CH
|
NZ |
|
Ryanair Holdings PLC
F:RY4D
|
IE |
|
Adaro Energy Indonesia TBK PT
IDX:ADRO
|
ID |
|
B
|
Bio-Techne Corp
F:TE1
|
US |
|
L
|
Ligand Pharmaceuticals Inc
F:LGDN
|
US |
|
B
|
Bridgestone Corp
DUS:BGT
|
JP |
|
C
|
Ceconomy AG
XHAM:CEC1
|
DE |
Wall St Price Targets
AT2 Price Targets Summary
Atara Biotherapeutics Inc
According to Wall Street analysts, the average 1-year price target for AT2 is 10.0422 EUR with a low forecast of 4.2616 EUR and a high forecast of 19.9368 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is AT2's stock price target?
Price Target
10.0422
EUR
According to Wall Street analysts, the average 1-year price target for AT2 is 10.0422 EUR with a low forecast of 4.2616 EUR and a high forecast of 19.9368 EUR.
What is the Revenue forecast for Atara Biotherapeutics Inc?
Projected CAGR
-5%
The compound annual growth rate for Revenue over the next 8 years is -5%.
What is the Operating Income forecast for Atara Biotherapeutics Inc?
Projected CAGR
2%
The compound annual growth rate for Operating Income over the next 5 years is 2%.
What is the Net Income forecast for Atara Biotherapeutics Inc?
Projected CAGR
-2%
The compound annual growth rate for Net Income over the next 8 years is -2%.
